The 20 Best Defective Apolipoprotein B-100 Doctors in Maryland, US

Seth Martin is a Cardiologist in Lutherville, Maryland. Dr. Martin is rated as an Advanced provider by MediFind in the treatment of Defective Apolipoprotein B-100. His top areas of expertise are High Cholesterol, Atherosclerosis, Heart Attack, Heart Bypass Surgery, and Pacemaker Implantation.

Christopher Haas, DO, specializes in cardiology and is board certified in cardiovascular disease and interventional cardiology by the American Board of Internal Medicine. He practices at UPMC Heart and Vascular Institute. Dr. Haas completed his medical education at Philadelphia College of Osteopathic Medicine, residency at Naval Hospital San Diego, and fellowship at Naval Hospital San Diego and George Washington University Medical Center. Dr. Haas is rated as an Advanced provider by MediFind in the treatment of Defective Apolipoprotein B-100. His top areas of expertise are Heart Attack, Heart Failure with Preserved Ejection Fraction (HFpEF), Angina, Atherectomy, and Heart Bypass Surgery.

Dr. Michael J. Blaha MD MPH is Professor of Cardiology and Epidemiology and presently serves as the Director of Clinical Research for the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Director of the Cardiometabolic Clinic, and Program Director for the Preventive Cardiology Fellowship. His clinical interests include primary and secondary prevention of cardiovascular disease, with emphasis on early intervention in patients with advanced subclinical atherosclerosis detected with cardiac computed tomography. Dr. Blaha represents the 4th generation of physicians in his family. After earning a BS in pre-medical studies and classical civilization at the University of Notre Dame in 2001, Dr. Blaha went to Vanderbilt University where in 2006 he received his MD as well as an MPH. in clinical epidemiology and biostatistics. Dr. Blaha then completed his Internal Medicine residency in the Osler Medical Housestaff Training Program at Johns Hopkins in 2009 before completing a fellowship in Cardiology at Johns Hopkins in 2012. In 2018, Dr. Blaha received the Dr. Fred Brancati award at Johns Hopkins for excellence in mentoring. He has mentored over 30 trainees, many of which have gone on to hold prominent academic appointments. In 2021, Dr. Blaha was named to the Clarivate Highly Cited Researcher List, representing the top 1% of world’s researchers, and was first named to the Baltimore Magazine Best Doctors List. In 2022, he received the Arthur S. Agatston Cardiovascular Disease Prevention Award. Clinically, he practices as a preventive cardiologist specializing in cardiometabolic disease and in the interpretation of cardiac CT. His clinic specializes in patients with cardiometabolic disease and advanced subclinical atherosclerosis, and the focused use of an array of lifestyle and pharmacotherapies to mitigate that risk. Dr. Blaha is rated as an Advanced provider by MediFind in the treatment of Defective Apolipoprotein B-100. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, High Cholesterol, Metabolic Syndrome, and Percutaneous Coronary Intervention (PCI).

Suzan Abdo is a primary care provider, practicing in Internal Medicine in Columbia, Maryland. Dr. Abdo is rated as a Distinguished provider by MediFind in the treatment of Defective Apolipoprotein B-100. Her top areas of expertise are Familial Hypercholesterolemia, Heterozygous Familial Hypercholesterolemia (HeFH), Hyperlipoproteinemia Type 4, and Defective Apolipoprotein B-100.

John Mulvey is a primary care provider, practicing in Family Medicine in Elkton, Maryland. Dr. Mulvey is rated as a Distinguished provider by MediFind in the treatment of Defective Apolipoprotein B-100. His top areas of expertise are Defective Apolipoprotein B-100, Heterozygous Familial Hypercholesterolemia (HeFH), Hyperlipoproteinemia Type 4, Kidney Transplant, and Pancreas Transplant.

Ajay Reddy is a primary care provider, practicing in Internal Medicine in Frederick, Maryland. Dr. Reddy is rated as a Distinguished provider by MediFind in the treatment of Defective Apolipoprotein B-100. His top areas of expertise are Familial Hypertriglyceridemia, Defective Apolipoprotein B-100, Homozygous Familial Hypercholesterolemia (HoFH), and Hyperlipoproteinemia Type 4.

Alan Shuldiner is an Endocrinologist in Baltimore, Maryland. Dr. Shuldiner is rated as an Advanced provider by MediFind in the treatment of Defective Apolipoprotein B-100. His top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Osteoporosis-Pseudoglioma Syndrome, Obesity, and Percutaneous Coronary Intervention (PCI).

Thorsten Leucker is a Cardiologist in Baltimore, Maryland. Dr. Leucker is rated as an Experienced provider by MediFind in the treatment of Defective Apolipoprotein B-100. His top areas of expertise are Apoplexy, Heart Attack, Heterozygous Familial Hypercholesterolemia (HeFH), and Homozygous Familial Hypercholesterolemia (HoFH).

Dr. Michael E. Carlos is a board-certified cardiologist specializing in cardiovascular disease prevention and long-term cardiac care. He earned his medical degree and completed his internal medicine residency at Northeastern Ohio University College of Medicine, followed by advanced cardiology training at the Medical College of Wisconsin and a fellowship in cardiac and peripheral interventions at the Cardiovascular Institute of the South.With a patient-centered approach, Dr. Carlos is dedicated to improving heart health through personalized care and evidence-based treatments. Dr. Carlos is rated as an Experienced provider by MediFind in the treatment of Defective Apolipoprotein B-100. His top areas of expertise are Hypertension, Glucocorticoid-Remediable Aldosteronism, Familial Dilated Cardiomyopathy, and Coronary Heart Disease.

Dr. Erin D. Michos is a Professor of Medicine within the Division of Cardiology at Johns Hopkins School of Medicine, with joint appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Director of Women's Cardiovascular Health and the Associate Director of Preventive Cardiology within the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. Dr. Michos is an internationally known expert in Preventive Cardiology and Women’s Health, having authored >700 publications and 11 book chapters. Her research involves (1) Women’s Cardiovascular Health; (2) Lipids and Lipid management; (3) Cardio-Kidney-Metabolic and Obesity disease management (4) Coronary artery calcium, inflammation and biomarkers of cardiovascular risk. She is the co-Editor-in-Chief for the American Journal of Preventive Cardiology. She is Co-Director of the IMPACT Center (Improving Participation Among Diverse Populations in Cardiovascular Clinical Trials) at Johns Hopkins, funded by the American Heart Association (AHA). She is a co-investigator in several NIH-funded studies including the Multi-Ethnic Study of Atherosclerosis and Atherosclerosis Risk in Communities cohorts. She has served as the Training Director for four AHA Strategic Focused Research Networks. She has mentored over 60 individuals and the recipient of 2 mentoring awards. Additionally, she was the recipient of the Nanette Wegner Award for Women’s Health Medical Leadership by the Women Heart Organization and the Donna Vogel Women’s Health Champion Award by Johns Hopkins University. Dr. Michos completed medical school at Northwestern University, Internal Medicine residency and Cardiology fellowship at the Johns Hopkins Hospital, and a Masters of Health Science degree at the Johns Hopkins Bloomberg School of Public Health. Dr. Michos is rated as an Experienced provider by MediFind in the treatment of Defective Apolipoprotein B-100. Her top areas of expertise are Atherosclerosis, Vitamin D Deficiency, Heart Failure, Percutaneous Coronary Intervention (PCI), and Thrombectomy.

Roger Blumenthal is the Kenneth Jay Pollin Professor of Cardiology, professor of medicine and director of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease in Baltimore, Maryland. His principal clinical and research interests involve: 1) strategies to improve cardiovascular risk assessment to identify those adults at elevated risk and those at very low risk of cardiovascular disease and 2) the optimal management of atherosclerotic vascular disease. He is an expert in the pathogenesis, treatment and prevention of atherosclerotic vascular disease. Dr. Blumenthal was the principal developer of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. He is on the official national spokesperson panel for the American Heart Association and has co-written more than 600 articles dealing with many aspects of coronary heart disease and atherosclerosis management. An experienced writer, Dr. Blumenthal is on the editorial board of Circulation, Cardiology Today, and The American College of Cardiology and Extended Learning Center. He is a fellow of the American College of Cardiology and the American Heart Association’s Epidemiology and Prevention Council. He was co-editor-in-chief of the textbook Preventive Cardiology – A Companion to Braunwald’s Heart Disease. He received his medical degree from Cornell Medical College, where he was awarded the Weiss Prize for Excellence in Clinical Medicine. He did his internal medicine and cardiology fellowship training at The Johns Hopkins Hospital before joining the Johns Hopkins cardiology faculty. Dr. Blumenthal was the 2019 recipient of the Landon School Anthony Kupka Distinguished Alumnus Award. He was co-chairperson of the 2019 American College of Cardiology/American Heart Guideline on prevention of cardiovascular disease. Dr. Blumenthal is rated as an Experienced provider by MediFind in the treatment of Defective Apolipoprotein B-100. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, Metabolic Syndrome, Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery.

Erik Marshall is a Cardiologist in Elkton, Maryland. Dr. Marshall has been practicing medicine for over 42 years and is rated as an Experienced provider by MediFind in the treatment of Defective Apolipoprotein B-100. His top areas of expertise are Aortic Valve Stenosis, Dilated Cardiomyopathy (DCM), Cardiomyopathy, Coronary Heart Disease, and Pacemaker Implantation.

"Dr. Aaron Kenigsberg received his medical degree from New York University School of Medicine. Dr. Kenigsberg completed his cardiology fellowship at the Beth Israel Deaconess Medical Center (formerly New England Deaconess Hospital) and Harvard Medical School. Dr. Kenigsberg is currently the Cath Lab Director at Holy Cross Hospital. His special interests include general and preventive cardiology, interventional cardiology, lipid management and interventional cardiology. Dr. Kenigsberg has also been recognized as one of the area's ""Top Doctors"" several times by the Washingtonian Magazine.". Dr. Kenigsberg is rated as an Experienced provider by MediFind in the treatment of Defective Apolipoprotein B-100. His top areas of expertise are Atrial Fibrillation, Angina, Heart Attack, and Atherosclerosis.

Feroz Padder is a Cardiologist and an Interventional Cardiologist in Laurel, Maryland. Dr. Padder is rated as an Experienced provider by MediFind in the treatment of Defective Apolipoprotein B-100. His top areas of expertise are Heart Attack, Hypertensive Heart Disease, Atherosclerosis, and Coronary Heart Disease.

Jelani Grant is a Cardiologist in Baltimore, Maryland. Dr. Grant is rated as an Experienced provider by MediFind in the treatment of Defective Apolipoprotein B-100. His top areas of expertise are Aortic Valve Stenosis, Atherosclerosis, Heart Failure, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Wendy Post is professor of medicine at the Johns Hopkins University School of Medicine and holds a joint appointment as professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Lou and Nancy Grasmick Professor of Cardiology. Dr. Post is a cardiologist at the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease and the Echocardiography Laboratory and is associate faculty at the Welch Center for Prevention, Epidemiology, and Clinical Research at Johns Hopkins University. She is Director of Cardiovascular Research for the Division of Cardiology and Director of Research for the Hopkins Cardiovascular Fellowship Training Program. Dr. Post received her undergraduate degree in biology from Harvard University. She earned her medical degree from Columbia College of Surgeons and Physicians, Columbia University. After completing her internship and residency at Harvard Medical School’s Beth Israel Hospital, Dr. Post received her master’s degree in epidemiology from the Harvard School of Public Health. She was a research fellow at the Framingham Heart Study, in Framingham, Mass., and completed a fellowship in cardiology at The Johns Hopkins Hospital. Dr. Post joined the Johns Hopkins faculty in 1997. Dr. Post’s research interests include prediction and prevention of coronary heart disease and sudden cardiac death, noninvasive imaging of subclinical atherosclerosis, genetics of cardiovascular disease, sex and racial/ethnic differences in cardiovascular disease, and cardiovascular disease in HIV/AIDS and COVID-19. She is the chair of the steering committee, and the principal investigator for the Hopkins field center for the NIH-funded Multi-Ethnic Study of Atherosclerosis (MESA). Dr. Post also leads Multicenter AIDS Cohort Study (MACS) Cardiovascular Disease sub-studies. She has been the PI for three R01 grants from NHLBI investigating cardiovascular disease in HIV, and is dual PI on the cardiology NHLBI training grant, which has been continuously funded for over 45 years. Dr. Post is a manuscript reviewer for multiple publications and is currently associate editor of Circulation. She has over 350 peer-reviewed research publications. Dr. Post was elected as a member of the American Society for Clinical Investigation (ASCI) in 2015. She mentors multiple medical students, medical house staff, fellows and junior faculty. She was a member of the Hopkins Professorial Promotions Committee and a former Johns Hopkins University Provost Fellow. She was co-chair of the Johns Hopkins University Committee on the Biomedical Scientific Workforce. Dr. Post is rated as an Experienced provider by MediFind in the treatment of Defective Apolipoprotein B-100. Her top areas of expertise are Atherosclerosis, Coronary Heart Disease, Carotid Artery Disease, Hormone Replacement Therapy (HRT), and Aortic Valve Replacement.

Dr. Robert Weiss is a Clarence Doodeman professor of cardiology as well as a professor of medicine and radiology at the Johns Hopkins University School of Medicine. Dr. Weiss directs a multi-disciplinary team at Johns Hopkins as well as collaborators at Cedars Sinai Medical Center in Los Angeles are dedicated to identifying the most important clinical, genetic, structural, contractile and metabolic causes of sudden cardiac death as well as the means to reverse the underlying pathology and lower risk. His research interests include energetic consequences and causes of heart failure, predictors of sudden cardiac death, non-invasive magnetic resonance, role of creatine kinase in heart failure, spectroscopy and imaging, coronary endothelial function and small animal cardiovascular imaging. Dr. Weiss received an undergraduate degree in physics form Dickinson College and a medical degree from Pennsylvania State University College of Medicine AOA Hershey Medical Center before joining Johns Hopkins in 1983 as an intern and assistant resident. Dr. Weiss has published extensively and has most recently been awarded a fellowship with the International Society of Magnetic Resonance in Medicine. Dr. Weiss is rated as an Experienced provider by MediFind in the treatment of Defective Apolipoprotein B-100. His top areas of expertise are Pulmonary Hypertension, Heart Attack, Pulmonary Veno-Occlusive Disease, and Coronary Heart Disease.

Kavita Sharma MD, is an Associate Professor of Medicine in Advanced Heart Failure/Transplant Cardiology in the Division of Cardiology at the Johns Hopkins University School of Medicine. She is the Director of the Johns Hopkins Heart Failure with Preserved Ejection Fraction Program. She sees patients at The Johns Hopkins Hospital, downtown campus. A cardiologist specializing in advanced heart failure, her clinical interests include advanced heart failure diagnosis and management, heart transplantation, and mechanical circulatory support including left ventricular assist devices. She has a specialized interest in heart failure with preserved ejection fraction (HFpEF), and directs one of the largest programs in the country dedicated to caring for patients with this condition. She is the principal investigator of numerous clinical and translational trials in HFpEF and leads a team of nurses, research coordinators, and fellows-in-training in this multi-faceted program. She is an invited speaker at national meetings in topic areas covering advanced heart failure and HFpEF. Dr. Sharma is a member of the American Heart Association, the American College of Cardiology, the Heart Failure Society of America, and the International Society of Heart and Lung Transplantation. Dr. Sharma is rated as an Experienced provider by MediFind in the treatment of Defective Apolipoprotein B-100. Her top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Cardiac Amyloidosis, Heart Transplant, and Fasciotomy.

Anushiravan Dadgar is a primary care provider, practicing in Internal Medicine in Rockville, Maryland. Dr. Dadgar is rated as an Advanced provider by MediFind in the treatment of Defective Apolipoprotein B-100. His top areas of expertise are Sitosterolemia, Necrosis, High Cholesterol, and Hypertensive Heart Disease.

Martin Albornoz is a Cardiologist in Catonsville, Maryland. Dr. Albornoz is rated as an Experienced provider by MediFind in the treatment of Defective Apolipoprotein B-100. His top areas of expertise are Heart Attack, Apoplexy, Angina, Pacemaker Implantation, and Angioplasty.